🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center, open label phase II clinical study is performed in patie...
Status
Active Not Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2021-12-07
Trial ID
NCT05020457
This is a phase 2 study to evaluate zimberelimab (AB122) combined with domv...
Status
Active Not Recruiting
Location
Research Site
Start Date
2021-02-08
Trial ID
NCT04736173
Treatments Being Tested
The purpose of this study is to learn about the safety and effects of the s...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-12-10
Trial ID
NCT06704724
In this four-part study, NKTR-214 was administered in combination with nivo...
Status
Completed
Location
UCSD, Moores Cancer Center
Start Date
2016-12-19
Trial ID
NCT02983045
The primary objectives of this study were: to assess the safety and tolerab...
Status
Completed
Location
Mayo Clinic Phoenix
Start Date
2019-08-15
Trial ID
NCT04047862
Lung cancer is one of the malignant tumors with high morbidity and mortalit...
Status
Completed
Location
Shanghai pulmonary hospital, Tongji University
Start Date
2021-01-20
Trial ID
NCT04702009
This is an open, multicenter phase Ib/II clinical study. The goal of this s...
Status
Recruiting
Location
Liaoning Cancer Hospital
Start Date
2025-05-21
Trial ID
NCT06943820
This is a multicenter, randomized, open-label, phase III clinical study, to...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-09-10
Trial ID
NCT07174908
This is a randomized, multicenter, double-blind placebo-controlled phase 3 ...
Status
Unknown
Location
Regional Hospital Liberec
Start Date
2019-06-01
Trial ID
NCT03912389
Treatments Being Tested
This Phase 2, open-label, randomized study in non-small-cell lung cancer (N...
Status
Recruiting
Location
Pioneer Research Center, LLC
Start Date
2024-09-26
Trial ID
NCT06463665
Treatments Being Tested